WW 268 (Lisinopril 20 mg)
Pill imprint WW 268 has been identified as Lisinopril 20 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; coronary artery disease; heart failure (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WW 268 (Lisinopril 20 mg)
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
silicon dioxide colloidal
calcium phosphate dibasic anhydrous
ferric oxide red
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|24658-0243||Blu Pharmaceuticals LLC|
|66336-0741||Dispensing Solutions Inc. (repackager)|
|67544-0134||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.